Encore Medical to Present at Bank of America Health Care Conference on Tuesday, May 16, 2006
09 5월 2006 - 9:00PM
PR Newswire (US)
AUSTIN, Texas, May 9 /PRNewswire-FirstCall/ -- Encore Medical
Corporation (NASDAQ:ENMC) will present at the Bank of America
Health Care Conference in Las Vegas at the Four Seasons Hotel on
Tuesday, May 16, 2006. William W. Burke, Executive Vice President
and Chief Financial Officer, will present at 8:00 a.m. Pacific
time. The presentation will provide an overview of Encore's
products, market opportunities and competitive position. A live
audio webcast of the presentation will be accessible through Encore
Medical Corporation's Web site at http://www.encoremed.com/ . The
webcast will be available for two weeks following the presentation.
Encore Medical Corporation is a diversified orthopedic device
company that develops, manufactures and distributes a comprehensive
range of high quality orthopedic devices used by orthopedic
surgeons, physicians, therapists, athletic trainers and other
healthcare professionals to treat patients with musculoskeletal
conditions resulting from degenerative diseases, deformities,
traumatic events and sports-related injuries. Through its
Orthopedic Rehabilitation Division, Encore is a leading distributor
of electrical stimulation and other orthopedic products used for
pain management, orthopedic rehabilitation, physical therapy,
fitness and sport performance enhancement. Encore's Surgical
Implant Division offers a comprehensive suite of reconstructive
joint products and spinal implants. For more information, visit
http://www.encoremed.com/ . Contact: William W. Burke, Executive
Vice President - Chief Financial Officer (512) 832-9500 Media:
Davis Henley, Vice President - Business Development (512) 832-9500
Except for the historical information contained herein, the matters
discussed are forward-looking statements made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. These statements involve risks and uncertainties, such as
quarterly fluctuations in operating results, the timely
availability of new products, the impacts of competitive products
and pricing, the ability to grow the distribution networks for the
Company's products, the ability to continue to obtain long- term
financing, and the ability to locate and integrate past and future
acquisitions and other risks and uncertainties set forth in the
Company's filings with the Securities and Exchange Commission.
These risks and uncertainties could cause actual results to differ
materially from any forward-looking statements made herein.
DATASOURCE: Encore Medical Corporation CONTACT: William W. Burke,
Executive Vice President - Chief Financial Officer, , or media,
Davis Henley, Vice President - Business Development, , both of
Encore Medical Corporation, +1-512-832-9500 Web site:
http://www.encoremed.com/
Copyright
Encore Medical (NASDAQ:ENMC)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024
Encore Medical (NASDAQ:ENMC)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024
Encore Medical (나스닥)의 실시간 뉴스: 최근 기사 0
More Encore Medical (MM) News Articles